Patents Assigned to Rugby-Darby Group Companies, Inc.
  • Treating classic migraine
    Patent number: 5242949
    Abstract: This invention relates to a method for treating classical migraine headaches. Pursuant to this method, a therapeutic amount of .beta.-adrenergic-blocking agent is administered to a person suffering a migraine attack promptly upon onset of aura. The invention further relates to a method wherein the blocking agent is nasally administered.
    Type: Grant
    Filed: March 13, 1992
    Date of Patent: September 7, 1993
    Assignee: Rugby-Darby Group Companies, Inc.
    Inventors: Arthur H. Goldberg, Leonard Lachman
  • Nasal administration of benzodiazepine hypnotics
    Patent number: 4950664
    Abstract: Nasal administration of benzodiazepines is described as providing improved therapeutic effects as compared to conventional delivery techniques. The compositions comprise a benzodiazepine hypnotic in a pharmaceutically acceptable nasal carrier.
    Type: Grant
    Filed: September 16, 1988
    Date of Patent: August 21, 1990
    Assignee: Rugby-Darby Group Companies, Inc.
    Inventor: Arthur H. Goldberg